Sven Nelander
- E-mail:
- sven.nelander@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
More information is available to staff who log in.
Short presentation
This text is not available in English, therefore the Swedish version is shown.
Sven Nelander är professor i integrativ cancerforskning vid Uppsala Universitet. Han studerar tumörer i hjärnan och nervsystemet, med målet att utveckla nya behandlingar. Hans forskarteam vid Rudbecklaboratoriet har utvecklat en rad nya teknik för att åstadkomma detta, från nya patient-specifika försöksmodeller till storskaliga datoranalyser.
Publications
Selection of publications
- Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts (2021)
- Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations (2021)
- Modeling glioblastoma heterogeneity as a dynamic network of cell states (2021)
- Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma (2021)
- Integrative discovery of treatments for high-risk neuroblastoma (2020)
- A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma (2020)
- HCN Channel Activity Balances Quiescence and Proliferation in Neural Stem Cells and Is a Selective Target for Neuroprotection During Cancer Treatment (2020)
- BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells (2019)
- LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients (2019)
- Primary glioblastoma cells for precision medicine (2018)
- Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin (2017)
Recent publications
- Live Detection of Neural Progenitors and Glioblastoma Cells by an Oligothiophene Derivative (2023)
- Inference of glioblastoma migration and proliferation rates using single time-point images (2023)
- Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape (2022)
- MYCMI-7 (2022)
- Autocrine signaling can explain the emergence of Allee effects in cancer cell populations (2022)
All publications
Articles
- Live Detection of Neural Progenitors and Glioblastoma Cells by an Oligothiophene Derivative (2023)
- Inference of glioblastoma migration and proliferation rates using single time-point images (2023)
- Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape (2022)
- MYCMI-7 (2022)
- Autocrine signaling can explain the emergence of Allee effects in cancer cell populations (2022)
- Fast and accurate gene regulatory network inference by normalized least squares regression (2022)
- Knowledge of the perturbation design is essential for accurate gene regulatory network inference (2022)
- Optimal Sparsity Selection Based on an Information Criterion for Accurate Gene Regulatory Network Inference (2022)
- Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts (2021)
- Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations (2021)
- Modeling glioblastoma heterogeneity as a dynamic network of cell states (2021)
- Modeling glioblastoma heterogeneity as a dynamic network of cell states (2021)
- p53-Mediated Radiosensitization of 177Lu-DOTATATE in Neuroblastoma Tumor Spheroids (2021)
- NF1 regulates mesenchymal gliblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1 (2021)
- Inferring the experimental design for accurate gene regulatory network inference (2021)
- Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma (2021)
- Integrative discovery of treatments for high-risk neuroblastoma (2020)
- Growth-Inhibitory Activity of Bone Morphogenetic Protein 4 in Human Glioblastoma Cell Lines Is Heterogeneous and Dependent on Reduced SOX2 Expression (2020)
- A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma (2020)
- HCN Channel Activity Balances Quiescence and Proliferation in Neural Stem Cells and Is a Selective Target for Neuroprotection During Cancer Treatment (2020)
- Astrocytes enhance glioblastoma growth. (2020)
- Monotherapy efficacy of blood-brain barrier permeable small molecule reactivators of protein phosphatase 2A in glioblastoma (2020)
- Uncovering cancer gene regulation by accurate regulatory network inference from uninformative data (2020)
- BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells (2019)
- Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors (2019)
- Increasing the accuracy of glioblastoma subtypes (2019)
- Integrin alpha 10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival (2019)
- Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes (2019)
- LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients (2019)
- Primary glioblastoma cells for precision medicine (2018)
- Image-Based Detection of Patient-Specific Drug-Induced Cell-Cycle Effects in Glioblastoma (2018)
- Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression (2017)
- c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas (2017)
- Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin (2017)
- FC1000 (2017)
- Membrane-Depolarizing Channel Blockers Induce Selective Glioma Cell Death by Impairing Nutrient Transport and Unfolded Protein/Amino Acid Responses (2017)
- Safe and effective treatment of experimental neuroblastoma and glioblastoma using systemically administered triple microRNA-detargeted oncolytic Semliki Forest virus (2017)
- Loss of Conservation of Graph Centralities in Reverse-engineered Transcriptional Regulatory Networks (2017)
- Origin of the U87MG glioma cell line (2016)
- Simultaneous Multiplexed Measurement of RNA and Proteins in Single Cells (2016)
- Travelling wave analysis of a mathematical model of glioblastoma growth (2016)
- Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma (2016)
- Genome-wide association study identifies multiple susceptibility loci for multiple myeloma (2016)
- High sensitivity isoelectric focusing to establish a signaling biomarker for the diagnosis of human colorectal cancer (2016)
- Case-specific potentiation of glioblastoma drugs by pterostilbene (2016)
- ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells (2016)
- High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes (2015)
- Efficient exploration of pan-cancer networks by generalized covariance selection and interactive web content (2015)
- Efficient exploration of multi-cancer networks by generalized covariance selection and interactive web content (2015)
- Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells (2015)
- Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma (2015)
- Avoiding pitfalls in L-1-regularised inference of gene networks (2015)
- The Human Glioblastoma Cell Culture Resource (2015)
- Bridging the gaps in systems biology (2014)
- Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule (2014)
- Meta-Analysis of Neural Childhood Cancer Networks (2014)
- Functional association networks as priors for gene regulatory network inference (2014)
- Selective Calcium Sensitivity in Immature Glioma Cancer Stem Cells (2014)
- Searching for Synergies (2013)
- Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions (2013)
- Targeting SOX2 in glioblastoma cells reveals heterogeneity in SOX2 dependency
- Exploring large scale integrative networks of glioblastoma using hypothesis driven pattern search
- Decoding glioblastoma drug responses using an open access library of patient derived cell models
- Prioritization of candidate cancer genes on chromosome 17q through reverse engineered transcriptional regulatory networks in medulloblastoma groups 3 and 4
Conferences
